CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 4, July/August 2022 218 AFRICA 132. World Health Organization. Raised cholesterol. WHO. World Health Organization. Retrieved 2020 Sep 11, from https://www.who.int/gho/ ncd/risk_factors/cholesterol_text/en/ 133. Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1345–1422. 134. Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, et al. World Heart Federation Cholesterol Roadmap. Glob Heart 2017; 12(3): 179. 135. National Department of Health (NDoH), South African Medical Research Council (SAMRC), Demographic and Health Surveys – Macro International Inc. South Africa Demographic and Health Survey 1998. Pretoria: National Department of Health (NDoH); 1998. https:// www.samrc.ac.za/sites/default/files/files/2017-07-03/dhsfin1.pdf 136. Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, EchouffoTcheugui JB, et al. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Health 2018; 6(9): e998–1007. 137. Richter M, Baumgartner J, Wentzel-Viljoen E, Smuts CM. Different dietary fatty acids are associated with blood lipids in healthy South African men and women: the PURE study. Int J Cardiol 2014; 172(2): 368–374. 138. Peer N, Steyn K, Lombard C, Gaziano T, Levitt N. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study. Eur J Prev Cardiol 2014; 21(12): 1549–1556. 139. Naicker A, Venter CS, MacIntyre UE, Ellis S. Dietary quality and patterns and non-communicable disease risk of an Indian community in KwaZulu-Natal, South Africa. J Health Popul Nutr 2015; 33(1): 12. 140. Peer N, Lombard C, Steyn K, Levitt N. High prevalence of metabolic syndrome in the black population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) study. Eur J Prev Cardiol 2015; 22(8): 1036–1042. 141. Reiger S, Jardim TV, Abrahams-Gessel S, Crowther NJ, Wade A, Gomez-Olive FX, et al. Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study. PLoS One 2017; 12(10): e0187347. 142. Blom DJ, Raal F, Amod A, Naidoo P, Lai Y. Management of lowdensity lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS). Cardiovasc J Afr 2019; 30(1): 15–23. 143. Heart & Stroke Foundation South Africa. Cholesterol. 2017. http:// www.heartfoundation.co.za/cholesterol/ 144. World Health Organization. Hypertension [factsheet]. WHO. 2019. https://www.who.int/news-room/fact-sheets/detail/hypertension 145. Cifkova R, Fodor G, Wohlfahrt P. Changes in hypertension prevalence, awareness, treatment, and control in high-, middle-, and low-income countries: an update. Curr Hypertens Rep 2016; 18(8): 62. 146. Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet 2019; 394(10199): 652–662. 147. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The heart of 25 by 25: Achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation 2016; 133(23). 148. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. J Am Med Assoc 2017; 317(2): 165. 149. Maredza M, Bertram MY, Gómez-Olivé XF, Tollman SM. Burden of stroke attributable to selected lifestyle risk factors in rural South Africa. BMC Public Health 2016; 16(1): 143. 150. Basu S, Millett C. Social epidemiology of hypertension in middleincome countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 2013; 62(1): 18–26. 151. Chang AY, Gómez-Olivé FX, Manne-Goehler J, Wade AN, Tollman, S, Gaziano TA, et al. Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa. Bull World Health Org 2019; 97(1): 10–23. 152. Davids SFG, Matsha TE, Peer N, Erasmus RT, Kengne AP. Increase in blood pressure over a 7-year period in a mixed-ancestry South African population. S Afr Med J 2019; 109(7): 503. 153. Gómez-Olivé FX, Thorogood M, Clark B, Kahn K, Tollman S. Selfreported health and health care use in an ageing population in the Agincourt sub-district of rural South Africa. Glob Health Action 2013; 6. 154. Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Prabhakaran D, Gaziano T, et al. Hypertension prevalence, awareness, treatment, and control in selected LMIC communities: Results from the NHLBI/UHG network of centers of excellence for chronic diseases. Glob Heart 2016; 11(1): 47. 155. Motlhale M, Ncayiyana JR. Migration status and prevalence of diabetes and hypertension in Gauteng province, South Africa: effect modification by demographic and socioeconomic characteristics – a cross-sectional population-based study. Br Med J Open 2019; 9(9): e027427. 156. Ntuli ST, Maimela E, Alberts M, Choma S, Dikotope S. Prevalence and associated risk factors of hypertension amongst adults in a rural community of Limpopo Province, South Africa. Afr J Prim Health Care Fam Med 2015; 7(1). 157. Peer N, Steyn K, Lombard C, Gwebushe N, Levitt N. A high burden of hypertension in the urban black population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) Study. PLoS One 2013; 8(11): e78567. 158. Rheeder P, Muthembe T, Lawson S, Brink J. Diabetes and hypertension screening in Zandspruit, Johannesburg 2012–2014. S Afr Fam Prac 2016; 58(6): 219–224. 159. Wandai M, Day C. Trends in risk factors for non-communicable diseases in South Africa – May 2015. Westville, South Africa: Health Systems Trust; 2015: 103. https://www.hst.org.za/publications/HSTPublications/ Trends_NCD_SA_HST_28Aug2015.pdf 160. Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ. Reducing the sodium content of high-salt foods: Effect on cardiovascular disease in South Africa. S Afr Med J 2012; 102(9): 743–745. 161. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edn. Diabetes Res Clin Prac 2019; 157: 107843. 162. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204–1222. 163. Statistics South Africa. Mortality and causes of death in South Africa, 2016: Findings from death notification. Pretoria: Statistics South Africa; 2018. Report No: Vol Statistical Release P0309.3. 164. Manne-Goehler J, Atun R, Stokes A, Goehler A, Houinato D,
RkJQdWJsaXNoZXIy NDIzNzc=